1. Home
  2. ACOG vs LSBK Comparison

ACOG vs LSBK Comparison

Compare ACOG & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • LSBK
  • Stock Information
  • Founded
  • ACOG 2000
  • LSBK 1891
  • Country
  • ACOG Canada
  • LSBK United States
  • Employees
  • ACOG N/A
  • LSBK N/A
  • Industry
  • ACOG
  • LSBK Savings Institutions
  • Sector
  • ACOG
  • LSBK Finance
  • Exchange
  • ACOG Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • ACOG 80.3M
  • LSBK 90.0M
  • IPO Year
  • ACOG N/A
  • LSBK 2006
  • Fundamental
  • Price
  • ACOG $9.33
  • LSBK $15.80
  • Analyst Decision
  • ACOG Strong Buy
  • LSBK
  • Analyst Count
  • ACOG 1
  • LSBK 0
  • Target Price
  • ACOG $20.00
  • LSBK N/A
  • AVG Volume (30 Days)
  • ACOG 76.9K
  • LSBK 2.6K
  • Earning Date
  • ACOG 08-14-2025
  • LSBK 07-23-2025
  • Dividend Yield
  • ACOG N/A
  • LSBK 3.42%
  • EPS Growth
  • ACOG N/A
  • LSBK 27.62
  • EPS
  • ACOG N/A
  • LSBK 0.89
  • Revenue
  • ACOG $2,928,654.00
  • LSBK $25,795,000.00
  • Revenue This Year
  • ACOG N/A
  • LSBK N/A
  • Revenue Next Year
  • ACOG N/A
  • LSBK N/A
  • P/E Ratio
  • ACOG N/A
  • LSBK $17.70
  • Revenue Growth
  • ACOG N/A
  • LSBK N/A
  • 52 Week Low
  • ACOG $3.75
  • LSBK $11.80
  • 52 Week High
  • ACOG $11.40
  • LSBK $16.95
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • LSBK 60.06
  • Support Level
  • ACOG N/A
  • LSBK $15.68
  • Resistance Level
  • ACOG N/A
  • LSBK $15.73
  • Average True Range (ATR)
  • ACOG 0.00
  • LSBK 0.07
  • MACD
  • ACOG 0.00
  • LSBK -0.03
  • Stochastic Oscillator
  • ACOG 0.00
  • LSBK 75.00

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: